Dennis McGrath

Dennis M.
McGrath is currently Director at Noninvasive Medical Technologies, Inc. since 2007; Independent Director at Citius Pharmaceuticals, Inc. since 2023; Independent Director at DarioHealth Corp.
since 2013; Director at BioVectra, Inc. since 2017; Director at Gadsden Growth Properties LP; Director at LIV Process, Inc.; Director at Veris Health, Inc. since 2021; Independent Director at Citius Oncology, Inc. since 2024; President & Chief Financial Officer at PAVmed, Inc. since 2022; Member of The American Institute of Certified Public Accountants; Member of New Jersey Society of Certified Public Accountants; Member of Pennsylvania Institute of Certified Public Accountants; Trustee at Manor College since 2015; and Chief Financial & Accounting Officer at Lucid Diagnostics, Inc. since 2023.
Former roles include Chief Executive Officer & Director at Radiancy, Inc. from 2009 to 2011; Chief Executive Officer at Mustard Seed Bible Book Stores, Inc.; Director at LCA-Vision, Inc.; President, Chief Financial Officer & Director at FC Global Realty, Inc. from 2011 to 2017; Director at EV Transportation, Inc.; Chief Financial Officer, Director & Executive VP at Tri Span, Inc. from 1996 to 1999; Director at RICOMM Systems, Inc. from 2003 to 2009; Director at Embrella Cardiovascular, Inc. from 2007 to 2009; Director at Gadsden Properties, Inc. from 2019 to 2020; President, Chief Financial Officer & Director at PhotoMedex Technology, Inc. from 2011 to 2017; Director at Cagent Vascular, Inc. from 2014 to 2024; Director at BioVector, Inc.; Chief Financial Officer at Think New Ideas, Inc. from 1999 to 2000; Chief Operating Officer-Internet Practice at The Hackett Group, Inc. from 1999 to 2000; Member-Visitors Board at Taylor University; and Chief Financial Officer & EVP-Operations at Icon Identity Solutions, Inc. from 1996 to 1999.
Education includes an undergraduate degree from LaSalle University conferred in 1979.